Michael Krall, Chief Executive Officer of PURE Bioscience, presides over the Closing Bell.

About PURE Bioscience:

PURE Bioscience develops and markets technology-based bioscience products that provide solutions to numerous global health challenges, including Staph (MRSA). SDC, PURE Bioscience's flagship technology, is the first new disinfectant active to be registered by the EPA in more than 30 years, and "Powered by SDC" disinfectants combine extraordinary broad spectrum antimicrobial action with a previously unattainable safety profile. SDC is a patented, aqueous non-toxic antimicrobial which is an electrolytically generated source of stabilized ionic silver that can serve as the basis for a broad range of products in diverse markets. PURE also manufactures and sells varying strengths of SDC concentrate as an active ingredient, additive or preservative for inclusion in third-party products.

Organizations interested in obtaining NASDAQ-listed company bell ringing ceremony photographs for press purposes, must first receive approval from the listed company before requesting photographs from NASDAQ. Please provide the company contact information from whom you received approval to Jolene Libretto at jolene.libretto@nasdaq.com. Kindly credit © 2008, The Nasdaq Stock Market, Inc. Reprinted with permission.

For all other photography inquiries, please contact NASDAQ’s photographer, Rob Tannenbaum at rob.tannenbaum@nasdaq.com.

© 2008, The NASDAQ OMX Group, Inc. Reprinted with permission.

Copyright | Disclaimer | Trademarks | Privacy Statement | Contact Us | Help | Search